Dr Ashwin Dhanda
Honorary Associate Professor in Hepatology
Peninsula Medical School (Faculty of Health)
I am a Consultant Hepatologist and Clinician Scientist with an interest in translational research relating to inflammatory liver diseases, particularly alcohol-related liver disease. I am part of a national MRC funded consortium aiming to minimise death from alcoholic hepatitis and am leading a workstream to validate a novel bioassay to measure response to glucocorticoid (steroid) therapy. I am seeking biomarkers of survival from alcohol-related liver disease including measures of immune function and circulating microbiome. I am also Chief Investigator of a pilot randomised controlled trial of Functional Imagery Training to treat alcohol dependence in patients with alcohol-related liver disease.
On a national level I lead the British Association for the Study of the Liver (BASL) Special Interest Group for alcohol-related liver disease (https://www.basl.org.uk/index.cfm/content/page/cid/35). This multidisciplinary group brings together active clinicians and researchers to develop national studies and trials in alcohol-related liver disease.
I am an active clinician as a Consultant Hepatologist and manage patients with acute and chronic liver disease at the South West Liver Unit at Derriford Hospital, University Hospitals Plymouth NHS Trust (https://www.plymouthhospitals.nhs.uk/dhanda-a).
BSc (Hons), University of Edinburgh 2000
MBChB, University of Edinburgh 2003
MRCP, Royal College of Physicians of London 2006
PGCert Health Education, St George's University of London 2007
PhD, University of Bristol 2014
FRCP, Royal College of Physicians of London 2021
Roles on external bodies
Key publications are highlightedJournals